Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. - Wikidata - awgldk - TriplyDB

Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds.

Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds.

http://www.wikidata.org/entity/Q34207468

about

Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adults Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method Cardiovascular risk and statin use in the United States Algorithm for predicting CHD death risk in Turkish adults: conventional factors contribute only moderately in women Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction.Information theoretical analysis of aging as a risk factor for heart disease Physiological Changes in Older Adults and Their Effect on Diabetes Treatment.Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study.A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients.The U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life.Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants.Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults.The potential for deprescribing in care home residents with Type 2 diabetes Statin treatment in the elderly: how much do we know?Racial differences in antilipemic use and lipid control in high-risk older adults: post-Medicare Part D.General Practitioners' Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study.Nutrition initiatives in the context of population aging: where does the United States stand?Future direction of geriatrics: "gerogeriatrics".Do statins cause diabetes?Management of diabetic nephropathy in older patients: a need for flexible guidelines.Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.Diabetes management in older people: a focus on cardiovascular risk reduction.The reverse metabolic syndrome in the elderly: Is it a "catabolic" syndrome?Statin prescribing according to gender, age and indication: what about the benefit-risk balance?Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol.Effect of Statin Therapy on Mortality in Older Adults Hospitalized with Coronary Artery Disease: A Propensity-Adjusted Analysis.Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study.Discussion around statin discontinuation in older adults and patients with wasting diseases.[Lipid lowering therapy in geriatric patients].Statin use among older Finns stratified according to cardiovascular risk.Statin use and pain in older people with cancer: a cross-sectional study.Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study.Extent and quality of drug use in community-dwelling people aged ≥75 years: A Swedish nationwide register-based study.Inception and deprescribing of statins in people aged over 80 years: cohort study.High Sensitivity Cardiac Troponin T and Cognitive Function in the Oldest Old: The Leiden 85-Plus Study.Trajectory of Total Cholesterol in The Last Years of Life Over Age 80 Years. Cohort Study of 99,758 Participants.Changing profile of health and function from age 70 to 85 years.Older statin initiators in Finland - cardiovascular risk profiles and persistence of use.

P2860

Q26796403-E7CD8402-A03B-419B-B370-E8D8E196C617 Q28081914-4A816431-2DC5-450D-A8C2-FE3739F6AB46 Q30525580-5B1184B5-E853-423B-9CB0-E335D62F2828 Q33599663-3CEC5521-BC7A-4B28-A7B6-583DC40D22FA Q33814237-1C72D016-5300-4564-8CAE-47A2E7AF548D Q34032851-C3A89746-7C5E-497B-B20B-2F19BED4EBFC Q34701292-BF68E0B5-8BF5-46FE-8D57-55B0BE5F1CEA Q35636879-91B05E94-2747-4C0F-AB04-B0B9D3FA7DAB Q35910471-0226497F-B57A-4673-A701-0B2B065CB790 Q36211920-950D5764-C873-420C-B0CB-46D9A436E5F9 Q36363183-06A91127-7DED-4C44-B2EB-A34D671F04E0 Q36467465-417FC1BA-6140-4FC2-AB30-A144A150B65B Q36494871-DBDA8BC8-7D0E-4020-9D90-A019919AC5EB Q37001217-58C919AF-A502-4579-B5E9-765F73DBFC8C Q37056755-3A4E71FA-F5DE-4E1B-B3B3-12BC9D247C29 Q37180162-BD2D6417-5AB4-4EF0-B2E1-0394AC8AEB44 Q37241199-6FD6BFF2-1A24-425A-95BE-5A4565BD75F1 Q37585702-CB489463-86D2-4A0C-888B-37E8CDE608A2 Q37984091-DFB9B0C6-4F70-47EB-B4E5-60B4FFDC1C3F Q37993585-C0A05D64-B036-4C6C-95FC-037FB7100FBF Q38086101-78AFA7EC-9277-4CD2-959A-B3079DC12BAA Q38241645-C3DED7FA-9D13-47BF-AC98-F045D8EEDDE5 Q38376542-6E840C72-537E-4CCB-9B1A-7F97EE403CAA Q38977597-22C90AFD-4BC9-4B8A-913B-9B977D20031A Q40088285-06CCFFDE-61B2-4EBD-9EA1-1F29D38E048F Q40455288-BF17A5F0-8933-4EB3-9E83-B802A9065355 Q40704687-A0DFAFCF-6CB4-4F30-A4C0-C6054C222ECB Q40704753-A4D24EA0-F4C1-4466-8867-1DA46F2C7DF1 Q41662985-C390E7EA-1D51-4A5B-BF0F-E09ECF5241CA Q42662810-E181EAC3-B6C5-4C72-B1FE-F04243E6C3BF Q45342111-D74851F0-6C83-4ECA-9D9D-F3255D4F0420 Q46888848-94170AFA-880B-4BE4-964B-17C8F3531524 Q46975648-89F40EBB-8821-46C0-82E9-99055C4F838C Q47099751-0A6DB16F-0628-4A5C-B51D-7CE5D68BACBD Q47376630-EFAA5157-A0F6-4A11-B87A-D6FBFFED75A2 Q47632585-4FCF5212-964E-4A13-8999-976787A36A92 Q47641767-996B44DB-9227-427F-B85A-0EE997D87796 Q47651470-F39B5112-8069-4E0B-A850-E08A3FC2B0EC Q48742845-C1011343-02E4-4FC6-80B1-8162E9C83BF8 Q51243305-D32D230A-C291-489D-B0A9-A134C02D7959

P2860

Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds.

http://www.wikidata.org/entity/Q34207468

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@ast

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@en

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@nl

type

label

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@ast

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@en

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@nl

prefLabel

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@ast

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@en

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@nl

P1433

Q34207468-75BF4CD2-BB6B-4EAD-B4F1-58BDAC43A457

P1476

Q34207468-7583F5C4-B536-4E02-9DF4-B4E97756E9C5

P2093

Q34207468-43074BE8-A93B-44BC-82D2-F40018E64D43

Q34207468-80696062-1E76-4546-ACE7-75A70D7465E1

P2860

Q34207468-0490E669-B8BB-4A44-86BA-41571DFAFEA5

Q34207468-05CAEA4F-E956-4CF6-894C-CD8976724618

Q34207468-0BA1632C-0A71-4E6F-AA44-188EA4CFD379

Q34207468-14F8D686-C34D-40DA-BD39-FB16A9252A9A

Q34207468-170BBBD7-5605-4DD0-B5FC-E5946E8AE687

Q34207468-2A382B93-EFD8-482F-85A0-956306A718E1

Q34207468-2FB407CA-D3EF-4486-B594-0C1704DB455B

Q34207468-303BE86C-D5F8-499B-9A3D-CA18FF52A912

Q34207468-36A193D9-BDB7-4120-A20A-6A9FD101A648

Q34207468-455B9A03-0CB1-433C-96AD-35FF73361DD9

P304

Q34207468-CDEECB13-B2E4-4A9D-9EC7-C95E3F7B584F

P31

Q34207468-1425941D-5E1F-416D-A7EF-FDC6952E4D88

P356

Q34207468-DDB5F6BD-73BB-4B91-9F2C-E565CFD3E8E2

P433

Q34207468-3507B274-FA79-4B61-A526-73F5B45E3787

P478

Q34207468-F302D376-FB25-4361-B551-3934116C1803

P50

Q34207468-80A047A1-9852-4F31-BEA9-63F34F5ADAB1

P577

Q34207468-6E5E28E0-2EBD-4D6A-B839-5C10D65F57DC

P5875

Q34207468-ED81C890-FDD3-455F-BE3F-8423DAECE4E2

P698

Q34207468-A493C7A5-EC6A-46CB-8420-B8789BAC6DEF

P932

Q34207468-4DB13CA9-9CE6-4877-AFBF-4F9BF4AEA06A

P356

P1433

P1476

Lipid-lowering treatment to th ...... nd mortality in 80+-year olds.

@en

P2093

Jakob Kragstrup

http://www.w3.org/2001/XMLSchema#string

Line Kirkeby Petersen

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.

Ageing populations: the challenges ahead.

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.

P304

674-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AGEING/AFQ129

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Kaare Christensen

P577

2010-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47449655

http://www.w3.org/2001/XMLSchema#string

P698

20952373

http://www.w3.org/2001/XMLSchema#string

P932

2956535

http://www.w3.org/2001/XMLSchema#string